Nautilus Biotechnolgy
NAUT
NAUT
83 hedge funds and large institutions have $155M invested in Nautilus Biotechnolgy in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
36% less capital invested
Capital invested by funds: $243M → $155M (-$88.7M)
Holders
83
Holding in Top 10
4
Calls
$37K
Puts
$2K
Top Buyers
| 1 | +$5.51M | |
| 2 | +$1.14M | |
| 3 | +$1.06M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$832K |
| 5 |
CAM
Crown Advisors Management
Larkspur,
California
|
+$672K |
Top Sellers
| 1 | -$3.65M | |
| 2 | -$1.99M | |
| 3 | -$1.06M | |
| 4 |
Millennium Management
New York
|
-$619K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$598K |